JIA patients in transition towards adult ward
Showing 26 - 50 of >10,000
HIV, AIDS Trial in Abuja (PEPFAR Enhanced Standard of Care (PESCA), Peer Transition Advocate (PTA))
Active, not recruiting
- HIV
- AIDS
- PEPFAR Enhanced Standard of Care (PESCA)
- Peer Transition Advocate (PTA)
-
Abuja, FCT, NigeriaInstitute of Human Virology, Nigeria
May 3, 2022
Sickle Cell Disease Trial in France (pediatric-adult care transition program)
Recruiting
- Sickle Cell Disease
- pediatric-adult care transition program
-
Fort-de-France-La Martinique, La Martinique, France
- +7 more
Apr 14, 2022
MSUS Versus Serum Survivin and Lubricin Levels in Evaluation of
Not yet recruiting
- Juvenile Idiopathic Arthritis
- (no location specified)
Sep 14, 2022
Juvenile Idiopathic Arthritis Associated Uveitis Trial in Cairo (biologic DMARDs)
Active, not recruiting
- Juvenile Idiopathic Arthritis Associated Uveitis
- biologic DMARDs
-
Cairo, EgyptFaculty of medicine, Cairo university
Sep 12, 2022
Juvenile Idiopathic Arthritis, Malocclusion, Angle Class II Trial in Milan (Device: orthodontic - mandibular advancement clear
Not yet recruiting
- Juvenile Idiopathic Arthritis
- Malocclusion, Angle Class II
- Device: orthodontic - mandibular advancement clear aligner
-
Milan, Itali, ItalyUniversità di Milano, Ospedale maggiore Policlincio, IRCCS Cà Gr
Jul 19, 2022
Juvenile Idiopathic Arthritis
Not yet recruiting
- Psoriatic Arthritis, Juvenile
- Polyarticular Juvenile Idiopathic Arthritis
-
Seoul, Korea, Republic ofSeoul National University Hospital
Feb 22, 2023
Extended Cross-sectoral Nurse Follow-up After Discharge From a Geriatric Ward Trial (geriatric follow-up home visit after
Not yet recruiting
- Extended Cross-sectoral Nurse Follow-up After Discharge From a Geriatric Ward
- geriatric follow-up home visit after discharge
- (no location specified)
Oct 31, 2022
Access to Pediatric Rheumatology Centers for JIA Patients:
Recruiting
- Juvenile Idiopathic Arthritis
- semi-structured interview
-
Clermont-Ferrand, France
- +3 more
Jan 12, 2023
Type1diabetes Trial in Canada (Data platform +Quality Performance feedback reports)
Active, not recruiting
- Type1diabetes
- Data platform +Quality Performance feedback reports
-
Hamilton, Ontario, Canada
- +4 more
May 5, 2022
Stroke, Acute Trial in Asheville, Cullowhee (External Focus of Attention, Internal Focus of Attention)
Recruiting
- Stroke, Acute
- External Focus of Attention
- Internal Focus of Attention
-
Asheville, North Carolina
- +1 more
May 22, 2023
The LETS Study: A Longitudinal Evaluation of Transition Services
Completed
- Cerebral Palsy
- +2 more
- LIFEspan
- Non-LIFEspan
-
Toronto, Ontario, Canada
- +1 more
Sep 26, 2022
Affecting Factors in Juvenile Idiopathic Arthritis
Recruiting
- Arthritis, Juvenile Rheumatoid
- +2 more
-
Istanbul, Fatih, TurkeyIstanbul University
Aug 17, 2023
Congenital Heart Disease, Heart; Surgery, Heart, Functional Disturbance as Result Trial in Edmonton (Teaching session, Just TRAC
Active, not recruiting
- Congenital Heart Disease
- Heart; Surgery, Heart, Functional Disturbance as Result
- Teaching session
- +2 more
-
Edmonton, Alberta, CanadaStollery Children's Hospital
Apr 5, 2022
Celiac Disease, Celiac Disease in Children, Transition of Care Trial in Finland (CeliCAT form)
Enrolling by invitation
- Celiac Disease
- +4 more
- CeliCAT form
-
Kuopio, Finland
- +3 more
Jun 28, 2022
Healthy, Pharmacokinetic Trial in Bangkok (Regimen 1 (Oral primaquine), Regimen 2 (IV primaquine phosphate), Regimen 3 (IV
Not yet recruiting
- Healthy
- Pharmacokinetic
- Regimen 1 (Oral primaquine)
- +2 more
-
Bangkok, ThailandFaculty of Tropical Medicine, Mahidol University
Jul 5, 2023
Emergencies, Aging Trial in Rochester, Madison (Care Transitions Intervention)
Completed
- Emergencies
- Aging
- Care Transitions Intervention
-
Rochester, New York
- +1 more
Jul 19, 2022
Fibrinogen to Albumin Ratio and C-reactive Protein to Albumin
Not yet recruiting
- Juvenile Idiopathic Arthritis
- fibrinogen to albumin ratio (AFR) and C-reactive protein to albumin ratio (CAR)
- (no location specified)
Aug 29, 2023
Eating Disorders Trial (Peer mentor intervention)
Not yet recruiting
- Eating Disorders
- Peer mentor intervention
- (no location specified)
Sep 13, 2022
Diabetes, Type 1 Trial in Canada (eHealth Tool)
Not yet recruiting
- Diabetes Mellitus, Type 1
- eHealth Tool
-
Markham, Ontario, Canada
- +5 more
Jun 23, 2022
Rheumatologic Disease Trial (Prototype 1, Prototype 2, Prototype 3)
Not yet recruiting
- Rheumatologic Disease
- Prototype 1
- +2 more
- (no location specified)
Sep 28, 2022
Juvenile Idiopathic Arthritis (JIA) Trial in Lake Success (Active tcVNS or Sham tcVNS, Active tcVNS)
Not yet recruiting
- Juvenile Idiopathic Arthritis (JIA)
- Active tcVNS or Sham tcVNS
- Active tcVNS
-
Lake Success, New YorkCohen Children's Medical Center, Northwell Health
Feb 1, 2023
Heart Failure Trial in Tehran (Acetazolamide, )
Not yet recruiting
- Heart Failure
- Acetazolamide
- placebo
-
Tehran, Tehran Heart Center, Iran, Islamic Republic ofHoushang bavandpour karvane
Jul 10, 2023
Juvenile Idiopathic Arthritis Trial in United States (Abatacept Injection, Usual Care)
Recruiting
- Juvenile Idiopathic Arthritis
- Abatacept Injection
- Usual Care
-
Birmingham, Alabama
- +25 more
Aug 16, 2022
Orencia in Japanese Children and Active Juvenile Arthritis of
Completed
- Undifferentiated Arthritis
- Non-Interventional
-
Shinjuku-ku, Tokyo, JapanLocal Institution
Jun 15, 2022
Polyarticular-course Juvenile Idiopathic Arthritis (JIA) Trial in Worldwide (Certolizumab Pegol (CZP))
Active, not recruiting
- Polyarticular-course Juvenile Idiopathic Arthritis (JIA)
- Certolizumab Pegol (CZP)
-
Little Rock, Arkansas
- +35 more
Dec 1, 2022